Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Ann Marie Mauer

AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348. PMID: 31339827.
      View in: PubMed
    2. Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz ARM, Assmann G, Rehberg M, Kanse SM, Nieswandt B, Walzog B, Reichel CA, Mannell H, Preissner KT, Deindl E. Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function. Cell Rep. 2016 08 23; 16(8):2197-2207. PMID: 27524614.
      View in: PubMed
    3. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 11561694.
      View in: PubMed
    4. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 10841143.
      View in: PubMed
    5. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 10611626.
      View in: PubMed
    6. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 17473657.
      View in: PubMed
    7. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 19439741.
      View in: PubMed
    8. Kaucikas M, Fitzpatrick A, Bryan E, Struve A, Henning R, Kosheleva I, Srajer V, Groenhof G, Van Thor JJ. Room temperature crystal structure of the fast switching M159T mutant of the fluorescent protein dronpa. Proteins. 2015 Mar; 83(3):397-402. PMID: 12367795.
      View in: PubMed
    9. Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61. PMID: 20730572.
      View in: PubMed
    10. Kim ES, Mauer AM, William WN, Tran HT, Liu D, Lee JJ, Windt P, Hong WK, Vokes EE, Herbst RS. A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 2009 Apr 15; 115(8):1713-22. PMID: 19208430.
      View in: PubMed
    11. Stinchcombe TE, Mauer AM, Hodgson LD, Herndon JE, Lynch TJ, Green MR, Vokes EE. Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430. J Thorac Oncol. 2008 Nov; 3(11):1301-7. PMID: 18978566.
      View in: PubMed
    12. Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11. PMID: 18758303.
      View in: PubMed
    13. Mauer AM, Cohen EE, Ma PC, Kozloff MF, Schwartzberg L, Coates AI, Qian J, Hagey AE, Gordon GB. A phase II study of ABT-751 in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008 Jun; 3(6):631-6. PMID: 18520803.
      View in: PubMed
    14. Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJ. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol. 2008 Feb 20; 26(6):848-55. PMID: 18281656.
      View in: PubMed
    15. Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67. PMID: 18166842.
      View in: PubMed
    16. Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Invest. 2007 Sep; 25(6):435-44. PMID: 17882655.
      View in: PubMed
    17. Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):515-22. PMID: 17255273.
      View in: PubMed
    18. Mauer AM, Rich ES, Schilsky RL. The role of cooperative groups in cancer clinical trials. Cancer Treat Res. 2007; 132:111-29. PMID: 17305018.
      View in: PubMed
    19. Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD, Villano JL, Kozloff M, Wade JL, Sciortino DF, Szeto L, Vokes EE. Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51. PMID: 17409864.
      View in: PubMed
    20. Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24. PMID: 16322304.
      View in: PubMed
    21. Mauer AM, Szeto L, Belt RJ, Schwartzberg LS, Hagey A, Coates AI, Meek KA, Cernohous P, Gordon GB. Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7137. PMID: 27944957.
      View in: PubMed
    22. Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Obasaju C, Haraf DJ, Salgia R, Vokes EE. A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):7062. PMID: 27944519.
      View in: PubMed
    23. Villaflor VM, Buckingham L, Gale M, Coon J, Mauer AM, Muzzafar T, Kaiser K, Zusag TW, Faber LP, Bonomi P. EGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol. 2005 Jun; 23(16_suppl):7077. PMID: 27944528.
      View in: PubMed
    24. Vokes EE, Cohen EE, Mauer AM, Karrison TG, Wong SJ, Skoog-Sluman LJ, Kozloff MF, Dancey J, Dekker A. A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC). J Clin Oncol. 2005 Jun; 23(16_suppl):5504. PMID: 27945465.
      View in: PubMed
    25. Hoffman PC, Mauer AM, Haraf DC, Lester EP, Szeto LL, Vokes EE. A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7113. PMID: 27944213.
      View in: PubMed
    26. Cohen EE, Haraf DJ, Stenson KM, Blair E, Brockstein BE, Mauer AM, Dekker A, Williams R, Lester E, Vokes EE. Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial. J Clin Oncol. 2005 Jun; 23(16_suppl):5506. PMID: 27945467.
      View in: PubMed
    27. Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005 Aug; 16(8):1320-5. PMID: 15919687.
      View in: PubMed
    28. Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF. A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer. Am J Clin Oncol. 2005 Feb; 28(1):65-9. PMID: 15685037.
      View in: PubMed
    29. Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83. PMID: 15547705.
      View in: PubMed
    30. Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJ. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58. PMID: 15292715.
      View in: PubMed
    31. Winegarden JD, Mauer AM, Otterson GA, Rudin CM, Villalona-Calero MA, Lanzotti VJ, Szeto L, Kasza K, Hoffman PC, Vokes EE. A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol. 2004 Jun; 15(6):915-20. PMID: 15151948.
      View in: PubMed
    32. Mauer AM, Ansari RH, Hoffman PC, Krauss SA, Taber D, Tembe SA, Gabrys GT, Cotter T, Schumm LP, Szeto L, Vokes EE. Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer. Ann Oncol. 2003 May; 14(5):722-8. PMID: 12702526.
      View in: PubMed
    33. Villano JL, Mauer AM, Vokes EE. A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain. Ann Oncol. 2003 Apr; 14(4):656-8. PMID: 12649117.
      View in: PubMed
    34. Winegarden JD, Mauer AM, Gajewski TF, Hoffman PC, Krauss S, Rudin CM, Vokes EE. A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6. PMID: 12581572.
      View in: PubMed
    35. Vokes EE, Charoentum C, Gordon GS, Rudin CM, Krauss SA, Hoffman PC, Mauer AM, Lee S, Watson S. Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer. Clin Lung Cancer. 2002 May; 3(4):265-70. PMID: 14662035.
      View in: PubMed
    36. Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EE. A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol. 2002 Apr; 13(4):539-45. PMID: 12056703.
      View in: PubMed
    37. Eng C, Mauer AM, Fleming GF, Bertucci D, Rotmensch J, Jacobs RH, Ratain MJ. Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. Ann Oncol. 2001 Dec; 12(12):1743-7. PMID: 11843253.
      View in: PubMed
    38. George CM, Haraf DJ, Mauer AM, Krauss SA, Hoffman PC, Rudin CM, Szeto L, Vokes EE. A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Invest New Drugs. 2001; 19(4):303-10. PMID: 11561689.
      View in: PubMed
    39. Vokes EE, Gordon GS, Mauer AM, Rudin CM, Krauss SA, Szeto L, Golomb HM, Hoffman PC. A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer. Clin Lung Cancer. 2000 Nov; 2(2):128-32. PMID: 14731323.
      View in: PubMed
    40. Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 1999 Aug; 39(8):838-44. PMID: 10504119.
      View in: PubMed
    41. Haase GM, Mauer AM, Reaman GH. Survivorship in childhood cancer: a case statement for enhancement of the role of the American Cancer Society. Task Force on Children and Cancer of the American Cancer Society. Cancer. 1998 Aug 15; 83(4):821-3. PMID: 9708952.
      View in: PubMed
    42. Vokes EE, Mauer AM. Multimodality therapy for esophageal cancer: an emerging role. Cancer J Sci Am. 1998 Jul-Aug; 4(4):226-9. PMID: 9689980.
      View in: PubMed
    43. Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80. PMID: 9681085.
      View in: PubMed
    44. Vokes EE, Mauer AM, Hoffman PC, Haraf DJ. Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy. Semin Oncol. 1998 Jun; 25(3 Suppl 8):28-32. PMID: 9704674.
      View in: PubMed
    45. Vokes EE, Masters GA, Mauer AM, Hoffman PC, Watson S, Golomb HM. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer. Semin Oncol. 1998 Feb; 25(1 Suppl 2):19-22. PMID: 9535207.
      View in: PubMed
    46. Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EE. Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64. PMID: 9440738.
      View in: PubMed
    47. Vokes EE, Mauer AM, Hoffman PC, Masters G, Watson S, Golomb HM. Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-67-S12-69. PMID: 9331125.
      View in: PubMed
    48. Vokes EE, Masters GA, Mauer AM, Haraf DJ, Hoffman PC, Golomb HM. Clinical studies of docetaxel (Taxotere) and concomitant chest therapy. Semin Oncol. 1997 Aug; 24(4 Suppl 14):S14-26-S14-29. PMID: 9335521.
      View in: PubMed
    49. Lauria MM, Hockenberry-Eaton M, Pawletko TM, Mauer AM. Psychosocial protocol for childhood cancer. A conceptual model. Cancer. 1996 Sep 15; 78(6):1345-56. PMID: 8826961.
      View in: PubMed
    50. Miller AA, Mauer AM, Tolley EA. Dosing of oral etoposide normalized for body surface area. Cancer Invest. 1995; 13(5):487-91. PMID: 7552815.
      View in: PubMed
    51. Miller AA, Tolley EA, Niell HB, Griffin JP, Mauer AM. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer. J Clin Oncol. 1993 Jun; 11(6):1179-88. PMID: 8388920.
      View in: PubMed
    52. Mauer AM. Adult and childhood acute lymphocytic leukemia: are they different diseases? Am J Hematol. 1993 Jan; 42(1):127-31. PMID: 8416287.
      View in: PubMed
    53. Mauer AM. The biological basis of age in the determination of prognosis in acute lymphoblastic leukemia. Cancer Invest. 1989; 7(6):601-5. PMID: 2630009.
      View in: PubMed
    54. Mauer AM. Acute lymphoblastic leukemia in a young adult. Hosp Pract (Off Ed). 1987 Sep 15; 22(9):145-50, 155-62. PMID: 3114285.
      View in: PubMed
    55. Hunter RF, Broadway P, Sun SL, Niell HB, Mauer AM. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation. Cancer Res. 1987 May 15; 47(10):2737-40. PMID: 3032414.
      View in: PubMed
    56. Mauer AM. New directions in the treatment of acute lymphoblastic leukemia in children. N Engl J Med. 1986 Jul 31; 315(5):316-7. PMID: 3459963.
      View in: PubMed
    57. George SL, Ochs JJ, Mauer AM, Simone JV. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol. 1985 Jun; 3(6):776-81. PMID: 3891922.
      View in: PubMed
    58. Thompson EI, Callihan TR, Mauer AM. Prophylaxis in severe granulocytopenia. Adv Intern Med. 1984; 29:193-214. PMID: 6369925.
      View in: PubMed
    59. Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AM. Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood. 1982 Oct; 60(4):959-67. PMID: 7115962.
      View in: PubMed
    60. Dahl GV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JV. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 1982 Oct; 60(4):856-63. PMID: 6896834.
      View in: PubMed
    61. Evans WE, Tsiatis A, Rivera G, Murphy SB, Dahl GV, Denison M, Crom WR, Barker LF, Mauer AM. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982 Apr 01; 49(7):1378-83. PMID: 7037164.
      View in: PubMed
    62. Murphy SB, Dahl GV, George SL, Karas J, Look AT, Simone JV, Mauer AM. Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. Leuk Res. 1982; 6(5):639-48. PMID: 7154706.
      View in: PubMed
    63. Ackerman TF, Mauer AM. Sounding board. Compensation and cancer research. N Engl J Med. 1981 Sep 24; 305(13):760-3. PMID: 7022217.
      View in: PubMed
    64. Brodeur GM, Pratt CB, Mauer AM. Case 50-1980: mixed malignant germ-cell tumor. N Engl J Med. 1981 Apr 23; 304(17):1047-8. PMID: 6259530.
      View in: PubMed
    65. George SL, Aur RJ, Mauer AM, Simone JV. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979 Feb 08; 300(6):269-73. PMID: 282457.
      View in: PubMed
    66. Rivera G, Murphy SB, Aur RJ, Verzosa MS, Dahl GV, Mauer AM. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission. Cancer. 1978 Dec; 42(6):2521-8. PMID: 282003.
      View in: PubMed
    67. Pratt CB, Smith JW, Woerner S, Mauer AM, Hustu HO, Johnson WW, Shanks EC. Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. Pediatrics. 1978 Jan; 61(1):30-4. PMID: 263871.
      View in: PubMed
    68. Hayes FA, Green AA, Mauer AM. Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res. 1977 Oct; 37(10):3766-70. PMID: 908020.
      View in: PubMed
    69. Mauer AM. Recent advances in pediatric oncology. Pediatr Res. 1977 Sep; 11(9 Pt 2):1008-10. PMID: 198732.
      View in: PubMed
    70. Murphy SB, Mauer AM. Terminal transferase and lymphoblastic neoplasms. N Engl J Med. 1977 Sep 01; 297(9):502-3. PMID: 267806.
      View in: PubMed
    71. Mauer AM, Murphy SB, Hayes FA. Evidence for recruitment and synchronization in leukemia and solid tumors. Cancer Treat Rep. 1976 Dec; 60(12):1841-4. PMID: 1026338.
      View in: PubMed
    72. Hayes FA, Mauer AM. Cell kinetics and chemotherapy in neuroblastoma. J Natl Cancer Inst. 1976 Sep; 57(3):697-9. PMID: 978773.
      View in: PubMed
    73. Lampkin BC, McWilliams NB, Mauer AM, Flessa HC, Hake DA, Fisher V. Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia. Br J Haematol. 1976 Jan; 32(1):29-40. PMID: 1063031.
      View in: PubMed
    74. Mauer AM, Murphy SB. Cell kinetics and practical consequences for therapy of acute leukemia. Proc Inst Med Chic. 1975 Jul-Sep; 30(8):247-50. PMID: 1187606.
      View in: PubMed
    75. Strauss RG, Bove KE, Jones JF, Mauer AM, Fulginiti VA. An anomaly of neutrophil morphology with impaired function. N Engl J Med. 1974 Feb 28; 290(9):478-84. PMID: 4129798.
      View in: PubMed
    76. Mauer AM, Lampkin BC, McWilliams NB. Effects of chemotherapeutic agents on cell cycle and cellular proliferation: basic and clinical considerations. Transplant Proc. 1973 Sep; 5(3):1181-4. PMID: 4517030.
      View in: PubMed
    77. Lampkin BC, McWilliams NB, Mauer AM. Cell kinetics and chemotherapy in acute leukemia. Semin Hematol. 1972 Apr; 9(2):211-23. PMID: 4502317.
      View in: PubMed
    78. Lampkin BC, Nagao T, Mauer AM. Synchronization and recruitment in acute leukemia. J Clin Invest. 1971 Oct; 50(10):2204-14. PMID: 5286686.
      View in: PubMed
    79. Wriedt K, Kauder E, Mauer AM. Defective myelopoiesis in congenital neutropenia. N Engl J Med. 1970 Nov 12; 283(20):1072-7. PMID: 5470848.
      View in: PubMed
    80. Nagao T, Mauer AM. Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med. 1969 Jul 03; 281(1):7-11. PMID: 5785754.
      View in: PubMed
    81. Canales ML, Mauer AM. Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N Engl J Med. 1967 Oct 26; 277(17):899-901. PMID: 4168739.
      View in: PubMed
    82. Saunders EF, Lampkin BC, Mauer AM. Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J Clin Invest. 1967 Aug; 46(8):1356-63. PMID: 16695924.
      View in: PubMed
    83. Lampkin BC, Mauer AM, McBride BH. Response of medulloblastoma to vincristine sulfate: a case report. Pediatrics. 1967 May; 39(5):761-3. PMID: 6026877.
      View in: PubMed
    84. Mauer AM, Fisher V. Characteristics of cell proliferation in four patients with untreated acute leukemia. Blood. 1966 Sep; 28(3):428-45. PMID: 5223200.
      View in: PubMed
    85. KRILL CE, SMITH HD, MAUER AM. CHRONIC IDIOPATHIC GRANULOCYTOPENIA. N Engl J Med. 1964 May 07; 270:973-9. PMID: 14122792.
      View in: PubMed
    Mauer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (313) concept(s)
    _
    Co-Authors Expand Description
    See all (25) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Physical Neighbors Expand Description
    _